Skip to main content Skip to search Skip to main navigation
Go to homepage

IGH Somatic Hypermutation Assay v2.0 (ABI)

Product information "IGH Somatic Hypermutation Assay v2.0 (ABI)"

2 master mixes for amplifying the regions Vƙ1-7and Jƙ1-5 which flank region 3 (CDR3). Further primers for the amplification of Kde and intragenic regions. Allows for bi-directional sequencing of clonal PCR products with just one sequencing-tag specific forward primer and one JH reverse primer, thus ensuring a more reliable and complete coverage of clonal products. Current ERIC (European Research Initiative on CLL) guidelines recommend bi-directional sequencing when determining the IGH SHM status.
Product type: PCR Assay
Regulatory status: RUO
Platform: ABI Fluorescence Detection
Reactions: 33 rxns
Storage temperature: -70 °C
Shipping method: Dry ice
Country of distribution: Germany
Questions?
Get in touch with us. We look forward to helping you.
IGH Somatic Hypermutation Assay v2.0 (ABI)
€1,300.00* (33 rxns, ABI Fluorescence Detection)